Tirzepatide (Mounjaro/Zepbound) targets both GLP-1 and GIP receptors two metabolic pathways instead of one
Neither is universally safer
Serious (less common, require medical attention) Pancreatitis Discontinue immediately if persistent severe abdominal pain occurs, particularly if it radiates to the back Gallbladder disease Rapid weight loss from any cause increases gallstone formation risk Acute kidney injury Primarily secondary to dehydration from vomiting and diarrhoea Hypoglycaemia More likely when semaglutide is combined with other glucose-lowering medications, particularly sulfonylureas or insulin Allergic reactions Discontinue and seek medical attention for swelling, difficulty breathing, or severe rash Drug Interactions What Pharmacists Check Before Dispensing Semaglutides mechanism of slowing gastric emptying creates a pharmacokinetic interaction with any oral medication whose absorption depends on gastric transit time
Fillers add volume by injecting a substance into the face, while Eve Titan works by stimulating your own facial muscles and supporting structures
How They Work: A Multi-Pronged Approach When GLP-1 RAs are introduced, they activate GLP-1 receptors in various parts of the body, leading to a cascade of beneficial effects: Appetite Regulation and Satiety : GLP-1 acts on the brain to signal fullness and reduce hunger
.webp)
